BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25383453)

  • 21. Kaempferol attenuates nonalcoholic fatty liver disease in type 2 diabetic mice via the Sirt1/AMPK signaling pathway.
    Li N; Yin L; Shang J; Liang M; Liu Z; Yang H; Qiang G; Du G; Yang X
    Biomed Pharmacother; 2023 Sep; 165():115113. PubMed ID: 37418974
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vigna nakashimae extract prevents hepatic steatosis in obese mice fed high-fat diets.
    Son Y; Jang MK; Jung MH
    J Med Food; 2014 Dec; 17(12):1322-31. PubMed ID: 25357150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ginsenoside Rb2 Alleviates Hepatic Lipid Accumulation by Restoring Autophagy via Induction of Sirt1 and Activation of AMPK.
    Huang Q; Wang T; Yang L; Wang HY
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28534819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mulberry extract inhibits oleic acid-induced lipid accumulation via reduction of lipogenesis and promotion of hepatic lipid clearance.
    Ou TT; Hsu MJ; Chan KC; Huang CN; Ho HH; Wang CJ
    J Sci Food Agric; 2011 Dec; 91(15):2740-8. PubMed ID: 22002411
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activating Adenosine Monophosphate-Activated Protein Kinase Mediates Fibroblast Growth Factor 1 Protection From Nonalcoholic Fatty Liver Disease in Mice.
    Lin Q; Huang Z; Cai G; Fan X; Yan X; Liu Z; Zhao Z; Li J; Li J; Shi H; Kong M; Zheng MH; Conklin DJ; Epstein PN; Wintergerst KA; Mohammadi M; Cai L; Li X; Li Y; Tan Y
    Hepatology; 2021 Jun; 73(6):2206-2222. PubMed ID: 32965675
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Garlic essential oil protects against obesity-triggered nonalcoholic fatty liver disease through modulation of lipid metabolism and oxidative stress.
    Lai YS; Chen WC; Ho CT; Lu KH; Lin SH; Tseng HC; Lin SY; Sheen LY
    J Agric Food Chem; 2014 Jun; 62(25):5897-906. PubMed ID: 24857364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Yhhu981, a novel compound, stimulates fatty acid oxidation via the activation of AMPK and ameliorates lipid metabolism disorder in ob/ob mice.
    Zeng HL; Huang SL; Xie FC; Zeng LM; Hu YH; Leng Y
    Acta Pharmacol Sin; 2015 Mar; 36(3):343-52. PubMed ID: 25732571
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
    Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
    Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cassia tora (Leguminosae) seed extract alleviates high-fat diet-induced nonalcoholic fatty liver.
    Tzeng TF; Lu HJ; Liou SS; Chang CJ; Liu IM
    Food Chem Toxicol; 2013 Jan; 51():194-201. PubMed ID: 23026700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of resveratrol derivatives on high-fat diet induced fatty liver by activating AMP-activated protein kinase.
    Choi YJ; Suh HR; Yoon Y; Lee KJ; Kim DG; Kim S; Lee BH
    Arch Pharm Res; 2014; 37(9):1169-76. PubMed ID: 24633463
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mulberry anthocyanins inhibit oleic acid induced lipid accumulation by reduction of lipogenesis and promotion of hepatic lipid clearance.
    Chang JJ; Hsu MJ; Huang HP; Chung DJ; Chang YC; Wang CJ
    J Agric Food Chem; 2013 Jun; 61(25):6069-76. PubMed ID: 23731091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coenzyme Q10 attenuates high-fat diet-induced non-alcoholic fatty liver disease through activation of the AMPK pathway.
    Chen K; Chen X; Xue H; Zhang P; Fang W; Chen X; Ling W
    Food Funct; 2019 Feb; 10(2):814-823. PubMed ID: 30675881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The GPR40 novel agonist SZZ15-11 improves non-alcoholic fatty liver disease by activating the AMPK pathway and restores metabolic homeostasis in diet-induced obese mice.
    Lei L; Gao X; Zhai J; Liu S; Liu Q; Li C; Cao H; Feng C; Chen L; Lei L; Pan X; Li P; Liu Z; Huan Y; Shen Z
    Diabetes Obes Metab; 2024 Jun; 26(6):2257-2266. PubMed ID: 38497233
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway.
    Qu LL; Yu B; Li Z; Jiang WX; Jiang JD; Kong WJ
    Phytother Res; 2016 Mar; 30(3):402-11. PubMed ID: 26634892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes.
    Kamikubo R; Kai K; Tsuji-Naito K; Akagawa M
    Mol Nutr Food Res; 2016 Oct; 60(10):2228-2242. PubMed ID: 27234712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 14-Deoxyandrographolide alleviates ethanol-induced hepatosteatosis through stimulation of AMP-activated protein kinase activity in rats.
    Mandal S; Mukhopadhyay S; Bandhopadhyay S; Sen G; Biswas T
    Alcohol; 2014 Mar; 48(2):123-32. PubMed ID: 24507479
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Viscothionin purified from mistletoe (Viscum album var. coloratum Ohwi) induces insulin secretion from pancreatic beta cells.
    Park JH; Kim YN; Kim JK; Park HY; Song BS
    J Ethnopharmacol; 2019 Apr; 234():172-179. PubMed ID: 30660712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hovenia Dulcis Extract Reduces Lipid Accumulation in Oleic Acid-Induced Steatosis of Hep G2 Cells via Activation of AMPK and PPARα/CPT-1 Pathway and in Acute Hyperlipidemia Mouse Model.
    Kim B; Woo MJ; Park CS; Lee SH; Kim JS; Kim B; An S; Kim SH
    Phytother Res; 2017 Jan; 31(1):132-139. PubMed ID: 27762456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatoprotective Effects of Soybean Embryo by Enhancing Adiponectin-Mediated AMP-Activated Protein Kinase α Pathway in High-Fat and High-Cholesterol Diet-Induced Nonalcoholic Fatty Liver Disease.
    Hong J; Kim S; Kim HS
    J Med Food; 2016 Jun; 19(6):549-59. PubMed ID: 27266339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of nonalcoholic fatty liver disease: role of AMPK.
    Smith BK; Marcinko K; Desjardins EM; Lally JS; Ford RJ; Steinberg GR
    Am J Physiol Endocrinol Metab; 2016 Oct; 311(4):E730-E740. PubMed ID: 27577854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.